On July 9, 2025, Monogram Technologies terminated its Exclusive License Agreement with Icahn School of Medicine, reverting intellectual property rights and agreeing to pay $4 million, which includes $500,000 cash and preferred stock valued at $3.5 million. This filing also involved creating new Series E Preferred Stock to fulfill this payment obligation, effective from July 11, 2025.